Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries, A Prospective Double-blinded Randomized Controlled Study

NCT07141589 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07141589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07141589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries, A Prospective Double-blinded Randomized Controlled Study
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2024
Completion date
November 25, 2025
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant, anterior segment surgeries, fentanyl, ketorolac, peribulbar block